CMRX – chimerix, inc. (US:NASDAQ)
Stock Stats
News
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday? [Yahoo! Finance]
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End [Yahoo! Finance]
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
Form 8-K CHIMERIX INC For: Dec 09
Form 8-K CHIMERIX INC For: Nov 12
Form 10-Q CHIMERIX INC For: Sep 30
Form 8-K CHIMERIX INC For: Nov 07
Form 4 CHIMERIX INC For: Oct 28 Filed by: MIDDLETON FRED A
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.